|
Hawthorn
by Steven Foster
Text © 2000 Steven Foster
Endless
variation
There are few
plant groups as confusing to botanists as hawthorns. A genus in the
rose family, Crataegus , as botanists call it, is now
recognized to have about 280 species found in northern temperate
regions, including North America, Europe, and northern Asia. The
plant group embodies the concept of endless variation, with numerous
hybrids and other variants, that in the late nineteenth century led
to the naming of upwards of 1,000 species of hawthorn for North
America alone! Botanists would do the world a favor if they reduced
the entire genus Crataegus to a single species. The group is
a taxonomic nightmare. Sixty or more species are known from Europe
and Asia, so North America is certainly the center of distribution
and diversity for the genus. The generic name Crataegus is
derived from a Greek word kratus, or strength, referring to
the hardness of the wood.
Hawthorns are large shrubs or small trees
usually with dark brown bark, flaking in scales. A prominent feature
of the branches is stout or slender, solitary or branched spines.
The white, and sometimes red, usually foul-smelling flowers are born
toward the end of leaf branches in round-top clusters. The delicate,
small rose-like flowers are beautiful and abundant, helping to earn
the tree a place of ornament in parks and lawns despite the nasty
spines protecting the trunk. The fruits, perhaps more showy than the
flowers, are rounded, oblong, or pear-shaped, relatively small (the
size of a large cultivated blueberry), range from orange-yellow,
scarlet, red, yellow, blue or black in color. The flesh is mealy and
dry, like that of rosehips.
Ironically, in eastern North America, the
part of the world with the greatest diversity and number of Crataegus species, one of the most extensively planted
hawthorn species is the English hawthorn, Crataegus laevigata (C. oxyacantha). It is distinguished by its three to
five-lobed leaves and blossoms with a purplish tint. This, too, is
the species most often listed as a medicinal plant in herbals of
European and American tradition, though many species are used
interchangeably for medicinal purposes. Most herb books list Crataegus oxyacantha, an older name synonymous with the
currently recognized name C. laevigata.
Several species of hawthorns are recognized
as sources of medicine. In Europe, one-seed hawthorn, Crataegus
monogyna is used along with C. laevigata. Both the leaves
and flowers as well as the fruits of these two species are used in
European herbal traditions. Both of these species occur throughout
Europe. Occasionally other hawthorns species are used such as Crataegus pentagyna, native to the Balkan Peninsula. A common
species of the eastern Mediterranean region Crataegus
azarolus is sometimes used in herbal medicine. Black hawthorn, Crataegus nigra has been the species of choice in eastern
European countries where it is grown on a commercial scale. In
traditional Chinese medicine, hawthorn fruits are known as
shan-zha. The fruits are derived from a
number of species, most notably C. pinnatifida, as well as C. cuneata, both of which have been grown in American
gardens.
Use by Native
Americans
Hawthorns have a
fascinating history of use. A number of North American hawthorns
were used as medicine by indigenous groups. The fruit of Crataegus chrysocarpa was used by the Potawatomi to treat
stomachache. The Ojibwa used a root decoction of one hawthorn to
treat diarrhea and dysentery. The Chippewa used a root decoction as
a tonic and strengthener for female diseases. The fruits were used
by the Fox as a diuretic for kidney and bladder ailments. The
Meskwaki also used hawthorn fruits for bladder ailments. They used
it as a general tonic, astringent, and a cardiac strengthener. The
Omaha-Ponca and the Winnebagos ate the mealy hawthorn fruits as food
during times of famine. The Cherokee ate the somewhat bitter fruits
as an appetite stimulant, as well as to improve circulation and
relieve cramps. One of the western North American species, C.
Douglasii, was used by the Thompson Indians for stomach
ailments. The bark, wood, or sap was decocted for this purpose. The
Kwakiutl chewed the leaves and used them as a poultice for wounds
and sores.
Use in
China
In traditional Asian
medicine, as well as herbal medicine in the European tradition, the
fruits have been widely used in prescriptions, taken over an
extended period of time, to treat hypertension, associated with
cardiac weakness, arteriosclerosis, and angina pectoris. It
stimulates blood circulation, improving flow to the coronary
arteries.
In China, the fruits of Crataegus
pinnatifida have been eaten to cure scurvy, taken as a mild
laxative, and for stomach ailments. The leaf and twigs have been
used as an antidote to poisoning with varnish. In Oriental medicine
the fruits are considered to have sour, sweet, slightly warming
qualities. They are utilized in prescriptions to dissolve food and
resolve stagnant digestion caused by accumulations of meat,
characterized by abdominal distention and pain, or diarrhea. The
fruits resolve congealed blood and are used for post partum
abdominal pains and heart pains. The charred fruits are taken in
prescriptions to relieve diarrhea and chronic dysentery. Hawthorn
was first mentioned as a drug in the Tang-Ben-Cao, a Chinese
herbal attributed to Su-Jing and others, dating to 659 AD. This work
is considered the worlds' first official pharmacopoeia. In modern
China, clinical experiments have shown that hawthorn fruit
preparations lowers blood pressure, affects systemic vasodilation,
lowers serum cholesterol levels, and is useful in the prevention and
treatment of arteriosclerosis.
Hawthorn emerges in
America
In Western
traditions, hawthorns are recognized for their utility in heart
ailments in relatively recent times. It is mostly absent from the
works of the famous Greek and Roman herbal writers, who mention it
only in passing for its edible, though less than delicious fruit.
The famous authors of English herbals such as Gerard give it little
attention. One is hard-pressed to find any historical Western
references beyond mention of the use of the fruits for stomach
ailments or to treat diarrhea. There is an interesting thread
through the plant's scant historical record. If uses in China are
compared with American Indian use and European folk use, cultures on
opposite sides of the world were in essence using hawthorns for very
similar purposes.
A curious article by J.C. Jennings of Chicago
was published in an 1896 issue of the New York Medical
Journal, which for the first time brought to light the
serendipitous use of hawthorn in the treatment of heart conditions.
He wrote, "There lived in the city of Ennis, County Clare, Ireland,
until about two years ago, a prominent physician named Greene, who
was well and favorably known over the greater part of Ireland and
parts of England and Scotland for his reputed ability to cure heart
disease.
"It was found after his death that he had
accomplished these cures solely with a fluid extract made from the Crataegus Oxyacantha, or hawthorn fruit. My brother, who
resides with in a few miles of Ennis, having informed me of these
things, I immediately wrote him, requesting that he send me some of
the fruit, to be used for testing the efficacy of the remedy, which
he did. I made a fluid extract according to the British
Pharmacopoeia, and have used it up to the present on forty-three
patients suffering with various forms of heart disease, and I must
say with the most gratifying results. . . . From these results my
deductions are that Crataegus Oxyacantha is superior to any
other of the well known and tried remedies at present in use in the
treatment of heart disease, becuase it seems to cure while the other
remedies are only palliative at best. "
Based upon Jennings enthusiasm for the herb,
by 1898, John Uri Lloyd, the most important pharmacist in the
history of American medicinal plants and owner of Lloyd Brothers
Pharmacists, Inc. of Cincinnati began manufacturing hawthorn
drugs.
In a Treatise on Crataegus (1921),
John Uri Lloyd recalls, "At first, we made only a tincture, or fluid
extract of the imported hawthorn berries, but comparative
investigations finally led us to the conclusion that this berry is
inferior to one of the American species, and accordingly we finally
placed the Specific Medicine of that Crataegus berry on the
market".
Unfortunately, Lloyd does not tell us which
American Hawthorn he found to be most superior. . .
John Uri Lloyd, himself, admits to delaying
the introduction of important drug plants including Crataegus and echinacea because of his own personal prejudices. He and his
brothers in Lloyd Brothers Pharmacists, Inc., had dismissed
hawthorn's potential in the treatment of heart disease as nothing
more than old wife's tales.
"My own delay in its general introduction is
to me now a subject of self-criticism. I am now more pronouncedly of
the opinion, as experiences multiply, that a person who is
restricted to laboratory experiments, especially if he be more or
less adversely prejudiced (as I was against Echinacea [and
hawthorn]), is not in a position to judge with discretion. Nor is a
laboratory man to be considered as "authority" in clinical
directions, which applies no less forcibly to inadequate drugs introduced under laboratory propaganda than to those worthy decried thereby."
Footnoting those comments, he mused,
"Seemingly, a number of 'experiences' were necessary to teach me
this lesson. Crataegus, commended first in the New York Medical
Journal for heart disease, was not only for months kept out of
Lloyd Brothers' list, but was even satirized by Mr. C.G. Lloyd
[younger brother and partner of J.U. Lloyd], in the following words:
'If there be anything in Crataegus, the hogs should have long
since discovered its value, because hogs eat the fruit in
quantities.' One correspondent asked, 'Well, did you ever know a hog
to be affected with heart disease?'"
Once introduced into the medical profession
in the late 1890s in the United States, physicians began singing the
praises of using hawthorn preparations in their practices. In the
Lloyd's Treatise on Hawthorn, Dr. H.P. Whitford of
Bridgewater, New York reflected, "I do not consider it a 'cure-all',
but no one agent has given better results in its sphere of action.
In weak hearts, with consequent capillary congestion, with effusion,
even where valves are so diseased as to eventually cause death, it
has proved of great benefit."
Active
constituents?
Hawthorn was
used clinically both in the United States and Europe in the first
half of this century for the treatment of heart disease. Modern
scientific investigations of the herb did not begin until the 1960s.
A number of classes of compounds including sterols, triterpenes,
flavonoids, catechins, proanthocyanidins and amines, all of which
have been shown to effect the cardiovascular system, were isolated
from the flowers and leaves as well as the fruits. However, no
single compound was found to be responsible for hawthorn's heart
tonic effects.
In Herbal Medicine, the late Dr.
Rudolf Fritz Weiss, write, "Again it was found that the complete
effect is achieved only through the combination of a whole number of
active principles. . .the sum of these individual constituents, in
the combination offered by natures, has unique and valuable
properties. It is obvious that the actions of the individual
elements are not merely additive or synergic, but that genuine
potentiation occurs."
Today, commercial preparations, primarily
manufactured in Europe are calibrated to contain flavonoids,
oligomeric procyanidins, and chlorogenic acid, among other
constituents. Timing of harvest as well as plant part used have been
found to be important factors to consider when developing hawthorn
drugs. For example, as much as three times the amount of
procyanidins are found in the fall leaves, compared with those
harvested in spring.
From Folk Medicine
to Modern Phytomedicine
As
a modern drug for the treatment of heart disease, hawthorn
preparations are widely recognized in European countries such as
Germany and Asian countries, including China. Hawthorn preparations
are the subject of German Commission E monographs. These monographs
which serve as the basis for regulation of herbal medicines in
Germany were first instituted in 1978, when the Commission,
consisting of professionals in pharmacy, medicine, industry, as well
as lay persons, was instituted. One of the first monographs produced
was on hawthorn. At the time, hawthorn drugs consisted of the flower
and leaves and/or fruits of hawthorn. Since the first monograph was
published in the late 1970s, it has been revised several times. The
most recent revision was in spring of 1996. Today, hawthorn drugs
approved for use in heart conditions in Germany consist of
preparations of the leaf with flowers of Crataegus monogyna or Crataegus laevigata. Drugs made solely from the fruits or
the leaves or the flowers are no longer allowed to carry drug
claims. Presumably, the reason for this change is that most clinical
studies with hawthorn have involved preparations including the leaf
with the flower.
Hawthorn preparations are prescribed by
physicians in Germany and elsewhere for the treatment of diminished
heart performance at the early stages of congestive heart failure,
for angina pectoris, and to help in long-term recovery from heart
attacks. It is also used to reduce a sensation of pressure or
anxiety in the heart area, age-related heart problems not requiring
digitalis, and mild forms of arrhythmias. Pharmacological and
clinical studies have shown that it helps increase the efficiency of
the heart by helping to improve the blood supply to the heart muscle
itself and by strengthening contractions. The heart is then able to
pump more blood to the rest of the body, while helping to dilate
blood vessels at the same time. Hawthorn extracts have also been
shown to improve circulation to the extremities by helping to reduce
resistance in the arteries.
Preparations and
caveats
Various European
hawthorn products, including those made from the fruits as well as
the leaves with flowers, some of which are available on the American
market as dietary supplements are standardized to oligomeric
procyanidins and flavonoids. The dose is 160 mg per day (divided
into two doses), or under a physician's supervision as much as 160
mg three times daily may be prescribed in Europe. The
pleasant-flavored, slightly tart, astringent tea of the berries is
traditionally made using about a teaspoon of the powdered fruits to
a cup of water.
No side effects or contraindications are
reported for hawthorn. However, heart disease is the number one
killer in the United States, and cannot be self-diagnosed of
self-treated. Heart disease or factors contributing to heart disease
should be identified and treated by a physician.
Here we have a medicinal plant that has
proved effective in the treatment of heart disease among Europeans
and Asians. Ironically, in North America, the land with the largest
number and greatest diversity of hawthorn species, its use for heart
conditions is relegated to historical obscurity.
References
- Brown, D. Herbal Prescriptions for
Better Health. Rocklin, Calif.: Prima Publishing, 1996.
- Foster, S. Herbal Renaissance.
Layton, Utah: Gibbs Smith Publisher, 1993.
- Foster, S. Herbs for Your Health,
Loveland, Colorado: Interweave Press, 1996.
- Hamon, N.W. Herbal medicine: Hawthorns
(Genus Crataegus). Canadian Pharmaceutical Journal . 121:
708-9; 724, 1988
- Hobbs, C. and S. Foster. Hawthorn - A
Literature Review. HerbalGram 22:18-33, 1989
- Lloyd, J.U. A Treatise on Crataegus Drug Treatise No. 29. Cincinnati: Lloyd Brothers
Pharmacists, Inc., 1921.
- Tyler, V. 1994. Herbs of Choice - The Therapeutic Use of Phytomedicinals. Binghamtom, New
York: Pharmaceutical Products Press, 1994.
- Weiss, R.F. Herbal Medicine (translated from German by A.R. Meuss). Beaconsfield, England:
Beaconsfield Publishers Ltd., 1988.
|